You are currently on the new version of our website. Access the old version .

Pharmaceutics, Volume 5, Issue 2

June 2013 - 9 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (9)

  • Review
  • Open Access
33 Citations
9,914 Views
18 Pages

The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer

  • Rebecca Johnson,
  • Nirupama Sabnis,
  • Walter J. McConathy and
  • Andras G. Lacko

Triple Negative Breast Cancer, TNBC, a highly aggressive and metastatic type of breast cancer, is characterized by loss of expression of the estrogen receptor (ER), progesterone receptor (PR), and a lack of overexpression of the human epidermal growt...

  • Review
  • Open Access
207 Citations
14,387 Views
24 Pages

Polysaccharide-Based Micelles for Drug Delivery

  • Nan Zhang,
  • Patricia R. Wardwell and
  • Rebecca A. Bader

Delivery of hydrophobic molecules and proteins has been an issue due to poor bioavailability following administration. Thus, micelle carrier systems are being investigated to improve drug solubility and stability. Due to problems with toxicity and im...

  • Communication
  • Open Access
7 Citations
8,107 Views
11 Pages

Efforts to take advantage of the beneficial activities of thyrotropin-releasing hormone (TRH) in the brain are hampered by its poor metabolic stability and lack of adequate central nervous system bioavailability. We report here novel and metabolicall...

  • Review
  • Open Access
112 Citations
14,321 Views
24 Pages

Delivery of Cancer Therapeutics Using Nanotechnology

  • Eun-Kyung Lim,
  • Eunji Jang,
  • Kwangyeol Lee,
  • Seungjoo Haam and
  • Yong-Min Huh

Nanoparticles have been investigated as drug carriers, because they provide a great opportunity due to their advantageous features: (i) various formulations using organic/inorganic materials, (ii) easy modification of targeting molecules, drugs or ot...

  • Article
  • Open Access
58 Citations
10,385 Views
17 Pages

Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles

  • Esther T. L. Lau,
  • Steven J. Giddings,
  • Salmaan G. Mohammed,
  • Paul Dubois,
  • Stuart K. Johnson,
  • Roger A. Stanley,
  • Peter J. Halley and
  • Kathryn J. Steadman

Zein was investigated for use as an oral-drug delivery system by loading prednisolone into zein microparticles using coacervation. To investigate the adaptability of this method to other drugs, zein microparticles were loaded with hydrocortisone, whi...

  • Article
  • Open Access
33 Citations
10,499 Views
16 Pages

Gemcitabine is an intravenously administered nucleoside analog chemotherapeutic agent. The ability to deliver this agent as an oral drug would allow greater flexibility of administration and patient convenience; however, attempts have been fraught wi...

  • Article
  • Open Access
13 Citations
14,796 Views
15 Pages

Development of a Novel Lipophilic, Magnetic Nanoparticle for in Vivo Drug Delivery

  • Thomas Linemann,
  • Louiza B. Thomsen,
  • Kristian G. du Jardin,
  • Jens C. Laursen,
  • Jesper B. Jensen,
  • Jacek Lichota and
  • Torben Moos

The aim of the present study was to evaluate the transfection potential of chitosan-coated, green-fluorescent magnetic nanoparticles (MNPs) (chi-MNPs) after encapsulation inside polyethylglycol (PEG)ylated liposomes that produced lipid-encapsulated...

  • Article
  • Open Access
10 Citations
9,756 Views
14 Pages

Psoriasis is a common, chronic and relapsing inflammatory skin disease. It affects approximately 2% of the western population and has no cure. Combination therapy for psoriasis often proves more efficacious and better tolerated than monotherapy with...

  • Review
  • Open Access
52 Citations
9,922 Views
12 Pages

Glutathione transferase (formerly GST) catalyzes the inactivation of various electrophile-producing anticancer agents via conjugation to the tripeptide glutathione. Moreover, several data link the overexpression of some GSTs, in particular GSTP1-1, t...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923